A retrospective study analysing non-adherence to treatments in patients with Multiple Myeloma
Latest Information Update: 20 Nov 2020
At a glance
- Drugs Ixazomib (Primary) ; Lenalidomide (Primary) ; Panobinostat (Primary) ; Pomalidomide (Primary) ; Thalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 20 Nov 2020 New trial record
- 19 Nov 2020 Results presented at the 23rd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research